ResultsEconomic Times
Ennature Bio Pharma posts Rs 5 cr PAT in Q2
Positive+67Company event
GreyOak summary
Ennature Bio Pharma reported a profit after tax of Rs 4.89 crore for the September quarter of FY27, marking its first results post-demerger from India Glycols Ltd. Revenue grew to Rs 78.46 crore, while EBITDA increased to Rs 10.34 crore compared to the previous year.
What it affects
- ENNATUREPositive +67
Posted Rs 4.89 cr PAT in Q2 FY27.Rolling sentiment Positive +42
Source
Read the original at Economic TimesMore ENNATURE news
No other recent stories about ENNATURE.
All ENNATURE news →